This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
French pharmaceutical giant Ipsen completed its initial public offering on the Euronext market, selling 14.6mm shares priced at €22.20 each for gross proceeds of €324mm ($379.8mm). The company had originally priced the shares between €21.70-25.20 each.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?